Hong Kong's Global Bio-chem H1 revenue falls 15% on export restrictions
Hong Kong's Global Bio-chem H1 revenue falls 15% on export restrictions
Overview
Hong Kong corn products maker's H1 revenue fell 15% yr/yr amid intensified competition
Gross profit margin dropped to 0.3% from 13.6% a year earlier
Company posted wider net loss as production costs rose and export markets weakened
Outlook
Company says global economic conditions and weak demand are weighing on market outlook
Global Bio-chem expects continued pressure from anti-dumping duties and trade restrictions in key markets
Company plans business diversification and technological upgrades to enhance operational efficiency and competitiveness
Result Drivers
EXPORT RESTRICTIONS - EU anti-dumping duties and US tariffs on amino acid products led to a shift from export to domestic sales, intensifying competition and pressuring results
HIGHER PRODUCTION COSTS - Average production cost per unit rose 15.9% while selling prices increased only 0.4%, sharply reducing gross profit margin
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue |
| HK$1.004 bln |
|
Analyst Coverage
The stock recently traded at 1 times the next 12-month earnings vs. a P/E of 1 three months ago
Reuters Recommended Reads
Aug 28 - China's Best Food interim revenue falls on market competition
Aug 25 - China's Shandong Xinhua profit drops on domestic, international competition
Aug 25 - China's Flat Glass Group H1 revenue falls amid weak global demand
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Global Bio-chem Technology
See all newsHong Kong's Global Bio-chem H1 revenue falls 15% on export restrictions
Brief: Global Bio-Chem Technology Says Wang Guicheng Resigns As Executive Director
Brief: Global Bio-Chem Technology's Unit Enters Cooperation Agreement With Shenzhou Bio-Tech
Brief: Global Bio-Chem Technology Posts FY Revenue HKD 2,278.5 Million
Brief: Global Bio-Chem Technology Proposes Share Consolidation Of Ten Existing Shares Into One Consolidated Share